Kristin Ryan
Gerontology · Arlington Heights, ILNPI 1972042521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 376 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$864
- Lilly USA, LLC$740
- AbbVie$573
- Amgen$507
- Abbott$468
- Corcept Therapeutics$400
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,728100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 67 | $864 |
| Lilly USA, LLC | 53 | $740 |
| AbbVie | 39 | $573 |
| Amgen | 32 | $507 |
| Abbott | 47 | $468 |
| Corcept Therapeutics | 20 | $400 |
| Xeris Pharmaceuticals, Inc. | 22 | $357 |
| Bayer | 10 | $234 |
| Boehringer Ingelheim | 11 | $221 |
| Sanofi-aventis U.S. LLC | 10 | $207 |
| Amneal Pharmaceuticals LLC | 11 | $197 |
| AstraZeneca(2 entities) | 12 | $190 |
| Tandem Diabetes Care, Inc. | 8 | $180 |
| Radius Health, Inc. | 7 | $131 |
| Recordati_rare_diseases_inc. | 3 | $59 |
| Ascendis Pharma Endocrinology Inc | 3 | $52 |
| Mannkind Corporation | 3 | $51 |
| BETA Bionics, Inc. | 4 | $50 |
| Amarin Pharma, Inc. | 3 | $48 |
| Nevro Corp. | 1 | $30 |
| EUSA Pharma (US) LLC | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Insulet Corporation | 1 | $21 |
| Alvogen Inc | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Tolmar, Inc. | 1 | $15 |
| BD | 1 | $15 |
| Amryt Pharma Holdings Ltd | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
How this compares
$5,740 in reported general payments places this provider in the 95th percentile of 180 gerontology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 227 | $405,924 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 226 | $297,073 |
| MounjaroTirzepatide | 175 | $262,781 |
| JardianceEmpagliflozin | 201 | $233,465 |
| FarxigaDapagliflozin Propanediol | 101 | $107,854 |
| TrulicityDulaglutide | 67 | $104,785 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $35,740 |
| Tresiba Flextouch U-100Insulin Degludec | 59 | $35,066 |
| Tresiba Flextouch U-200Insulin Degludec | 37 | $34,416 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 22 | $24,534 |
| JanuviaSitagliptin Phosphate | 21 | $24,046 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $24,019 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 103 | $13,263 |
| NovologInsulin Aspart | 39 | $13,143 |
| Novolog FlexpenInsulin Aspart | 59 | $12,997 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $864 | $419,066266 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $740 | $376,830267 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $207 | $297,073226 claims |
| Boehringer IngelheimJardiance | $221 | $233,465201 claims |
| AstraZenecaFarxiga | $190 | $107,854101 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $197 | $2,197165 claims |
| AbbVieSynthroid | $573 | $1,45013 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 180 gerontology providers in Illinois.
Other gerontology in Arlington Heights
- Julie KollinsArlington Heights$869
- Joseph StokesChicago$16K
- Stephanie VerderameRockford$15K
- Megan BonisNiles$15K
- Cheryl RogersKankakee$15K
- June LosurdoHinsdale$9K
- Hayley MillsMoline$7K
- Carlyn NewellOlympia Fields$7K
- Ann WaldronMatteson$6K
- Rhonda JohnsonRockford$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.